March 11, 2024
The Second Circuit recently made it harder for critics of workplace diversity, equity and inclusion efforts to mount legal challenges to those programs with its decision that an anti-DEI advocacy group didn't have standing to challenge a Pfizer fellowship geared toward historically underrepresented groups, experts said.
March 06, 2024
The Second Circuit declined Wednesday to revive an advocacy group's suit claiming a Pfizer diversity fellowship unlawfully discriminated against white and Asian workers, ruling the nonprofit had no legal foothold because it wouldn't specifically identify anyone allegedly harmed.